| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRM | Common Stock | Options Exercise | $2.36M | +20K | +44.56% | $118.04 | 64.9K | 07 Apr 2022 | Direct | F1 |
| transaction | CRM | Common Stock | Sale | -$4M | -20K | -30.83% | $200.00* | 44.9K | 07 Apr 2022 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CRM | Non-qualified Stock Option (Right to Buy) | Options Exercise | $0 | -20K | -24.55% | $0.00 | 61.5K | 07 Apr 2022 | Common Stock | 20K | $118.04 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. |
| F2 | Option is exercisable and vests over four years at the rate of 25% on March 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
Exhibit 24 - Power of Attorney